IBDEI1DE ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23292,1,4,0)
 ;;=4^R93.6
 ;;^UTILITY(U,$J,358.3,23292,2)
 ;;=^5019719
 ;;^UTILITY(U,$J,358.3,23293,0)
 ;;=R94.4^^87^993^16
 ;;^UTILITY(U,$J,358.3,23293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23293,1,3,0)
 ;;=3^Abnormal Kidney Function Studies
 ;;^UTILITY(U,$J,358.3,23293,1,4,0)
 ;;=4^R94.4
 ;;^UTILITY(U,$J,358.3,23293,2)
 ;;=^5019741
 ;;^UTILITY(U,$J,358.3,23294,0)
 ;;=R94.5^^87^993^17
 ;;^UTILITY(U,$J,358.3,23294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23294,1,3,0)
 ;;=3^Abnormal Liver Function Studies
 ;;^UTILITY(U,$J,358.3,23294,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,23294,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,23295,0)
 ;;=R94.6^^87^993^21
 ;;^UTILITY(U,$J,358.3,23295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23295,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,23295,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,23295,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,23296,0)
 ;;=R94.7^^87^993^5
 ;;^UTILITY(U,$J,358.3,23296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23296,1,3,0)
 ;;=3^Abnormal Endocrine Function Sutdies NEC
 ;;^UTILITY(U,$J,358.3,23296,1,4,0)
 ;;=4^R94.7
 ;;^UTILITY(U,$J,358.3,23296,2)
 ;;=^5019744
 ;;^UTILITY(U,$J,358.3,23297,0)
 ;;=R94.31^^87^993^4
 ;;^UTILITY(U,$J,358.3,23297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23297,1,3,0)
 ;;=3^Abnormal EKG
 ;;^UTILITY(U,$J,358.3,23297,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,23297,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,23298,0)
 ;;=R97.0^^87^993^67
 ;;^UTILITY(U,$J,358.3,23298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23298,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen 
 ;;^UTILITY(U,$J,358.3,23298,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,23298,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,23299,0)
 ;;=R97.1^^87^993^66
 ;;^UTILITY(U,$J,358.3,23299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23299,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,23299,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,23299,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,23300,0)
 ;;=R97.2^^87^993^68
 ;;^UTILITY(U,$J,358.3,23300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23300,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,23300,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,23300,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,23301,0)
 ;;=R97.8^^87^993^22
 ;;^UTILITY(U,$J,358.3,23301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23301,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,23301,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,23301,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,23302,0)
 ;;=R93.8^^87^993^12
 ;;^UTILITY(U,$J,358.3,23302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23302,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,23302,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,23302,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,23303,0)
 ;;=R93.1^^87^993^14
 ;;^UTILITY(U,$J,358.3,23303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23303,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,23303,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,23303,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,23304,0)
 ;;=R68.83^^87^993^48
 ;;^UTILITY(U,$J,358.3,23304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23304,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,23304,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,23304,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,23305,0)
 ;;=R68.2^^87^993^62
 ;;^UTILITY(U,$J,358.3,23305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23305,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,23305,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,23305,2)
 ;;=^5019552
